Gunpo-si, South Korea

Jun Won Lee


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jun Won Lee in Liver Disease Treatment.

Introduction

Jun Won Lee is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of liver diseases. His innovative work focuses on developing compounds that can effectively combat liver fibrosis and cirrhosis.

Latest Patents

One of Jun Won Lee's key patents is titled "Benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses." This invention relates to a novel benzopyran derivative that exhibits strong antagonistic activity on the TGF-β receptor. It is designed to be used as both a prophylactic and therapeutic agent for liver diseases, as well as various fibroplastic diseases such as hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, and dermatosclerosis.

Career Highlights

Throughout his career, Jun Won Lee has worked with prominent organizations, including SK Chemicals Co., Ltd. and the Korea Research Institute of Chemical Technology. His experience in these institutions has allowed him to advance his research and contribute to the development of effective treatments for serious health conditions.

Collaborations

Jun Won Lee has collaborated with esteemed colleagues, including Young-Dae Gong and Jin-Soo Seo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical field.

Conclusion

Jun Won Lee's innovative contributions to the treatment of liver diseases highlight the importance of research and development in pharmaceuticals. His work not only addresses critical health issues but also paves the way for future advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…